“There isn’t a simpler method to earn cash available in the market than to purchase an awesome firm below strain attributable to short-term issues.” So stated the most recent member of the Barron’s Roundtable, David Giroux of T. Rowe Value, at our annual gathering on Jan. 10, on Zoom. For higher—and worse—there’s lots to select from today, given a market selloff that has dragged the Nasdaq Composite into correction territory, and reveals no signal of ending.
On this week’s second 2022 Roundtable installment, Giroux highlights six shares that, to his…
